97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,630 Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05088369
(ClinicalTrials.gov)
November 11, 202112/10/2021Assessment of the Safety, Tolerability, and Pharmacokinetic of HM201A First-in-human, Double-blind, Placebo-controlled, Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Intravenous Doses of HM201 (Pegylated Human Adrenomedullin) in Healthy Subjects (Adults)Ulcerative Colitis;Crohn's DiseaseDrug: HM201;Drug: PlaceboSyneos HealthHimuka AM Pharma Corp.Completed18 Years55 YearsAll53Phase 1Australia